(Q61920824)
Statements
A Phase I/II Dose Escalation Clinical Trial to Assess Safety and Efficacy of VG101 to Treat the Symptoms of Vulvar and Vaginal Atrophy in Post-Menopausal Women (English)
0 references
June 2012
0 references
June 2013
0 references
40
0 references
45 year
0 references
65 year
0 references